Yahoo
    XETRA - Delayed Quote EUR

    Danaher Corporation (DAP.DE)

    204.70 -1.00 (-0.49%)
    At close: November 6 at 5:35:52 PM GMT+1
    Loading Chart for DAP.DE
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Democrats Win Midterms: 5 Best Healthcare and Insurance Stocks To Buy

    Democrats Win Midterms: 5 Best Healthcare and Insurance Stocks To Buy
    Insider Monkey 3h ago
    Are You Overpaying For Abbott Stock Versus Its Rivals?

    Are You Overpaying For Abbott Stock Versus Its Rivals?
    Trefis 3d ago
    O2 Investment Partners Announces Appointment of Rob Calice as Senior Director, Portfolio Operations

    O2 Investment Partners Announces Appointment of Rob Calice as Senior Director, Portfolio Operations
    Business Wire 3d ago
    Danaher (DHR) Stock Fair Value Rises After Higher Analyst Targets And Q3 Commentary

    Danaher (DHR) Stock Fair Value Rises After Higher Analyst Targets And Q3 Commentary
    Simply Wall St. 3d ago
    Guidance Up, Trend Intact: Mettler-Toledo Is Today's Double-Confirmation Stock

    Guidance Up, Trend Intact: Mettler-Toledo Is Today's Double-Confirmation Stock
    Trefis 4d ago
    Danaher (DHR) Wins FDA Clearance For Hemorrhagic Fever Test With Four Virus Detection

    Danaher (DHR) Wins FDA Clearance For Hemorrhagic Fever Test With Four Virus Detection
    Simply Wall St. 4d ago
    Microcarriers - Global Strategic Business Report 2026: Secure Your Share of $3.9 Billion by 2032 | Benchmark Corning, Danaher, Sartorius, and Thermo Fisher

    Microcarriers - Global Strategic Business Report 2026: Secure Your Share of $3.9 Billion by 2032 | Benchmark Corning, Danaher, Sartorius, and Thermo Fisher
    GlobeNewswire 4d ago
    Downstream Processing - Global Strategic Business Report 2026: Capitalize on 15.7% CAGR to US$128.9 Billion by 2032 as Danaher, Merck, Sartorius, and Thermo Fisher Reshape Biomanufacturing

    Downstream Processing - Global Strategic Business Report 2026: Capitalize on 15.7% CAGR to US$128.9 Billion by 2032 as Danaher, Merck, Sartorius, and Thermo Fisher Reshape Biomanufacturing
    GlobeNewswire 4d ago
    Cell Based Assays - Global Strategic Business Report 2026: Capitalize on the $30.5B Market by 2032 as Thermo Fisher, Danaher, Merck KGaA and Lonza Accelerate AI, 3D Cultures and Automation

    Cell Based Assays - Global Strategic Business Report 2026: Capitalize on the $30.5B Market by 2032 as Thermo Fisher, Danaher, Merck KGaA and Lonza Accelerate AI, 3D Cultures and Automation
    GlobeNewswire 4d ago
    Cell Counting - Global Strategic Business Report 2026: Capitalize on US$6 Billion Growth by 2032 as Abbott, Becton Dickinson, Bio-Rad, Danaher, and Sysmex Drive Automation

    Cell Counting - Global Strategic Business Report 2026: Capitalize on US$6 Billion Growth by 2032 as Abbott, Becton Dickinson, Bio-Rad, Danaher, and Sysmex Drive Automation
    GlobeNewswire 4d ago
    Life Science Instrumentation - Global Strategic Business Report 2026-2032 Featuring ACHB Enterprise, Agilent Technologies, BD, Bio-Rad Labs, Bruker Corp., ChromaCode, Danaher Corp., Emerson Electric Co., Eppendorf, GE Healthcare, Hitachi High-Tech Corp.

    Life Science Instrumentation - Global Strategic Business Report 2026-2032 Featuring ACHB Enterprise, Agilent Technologies, BD, Bio-Rad Labs, Bruker Corp., ChromaCode, Danaher Corp., Emerson Electric Co., Eppendorf, GE Healthcare, Hitachi High-Tech Corp.
    GlobeNewswire 4d ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: